Search results for "candidiasis"

showing 10 items of 160 documents

Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients

2017

0301 basic medicineContinuous renal replacement therapymedicine.medical_specialtyLetterCritical Illness030106 microbiologyHemodiafiltrationCritical Care and Intensive Care MedicineEchinocandinsLipopeptides03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCaspofunginHumansMedicineIntensive care medicinebusiness.industryCritically illlcsh:Medical emergencies. Critical care. Intensive care. First aid030208 emergency & critical care medicinelcsh:RC86-88.9Invasive candidiasisContinuous venovenous hemodiafiltrationAcute Kidney Injurymedicine.diseaseInvasive candidiasisRenal Replacement TherapychemistryAdsorptionCaspofunginbusinessCritical Care
researchProduct

Diagnosis of systemic candidiasis by enzyme immunoassay detection of specific antibodies to mycelial phase cell wall and cytoplasmic candidal antigens

1993

Diagnosis of systemic Candida infections was attempted by the use of an enzyme-linked immunosorbent assay (EIA) to detect IgG antibodies towards cell wall-bound and cytoplasmic candidal antigens. Cell wall antigens were sequentially solubilized by treatment of germinated blastoconidia of Candida albicans (ATCC 26555 strain) with beta-mercaptoethanol (beta ME extract) and digestion with Zymolyase 20T, a beta-glucanase preparation (Zymolyase extract). Protoplasts obtained after treatment with Zymolyase were osmotically lysed (cytoplasmic antigens). Sera were obtained from patients with systemic (n = 28) and superficial (n = 46) candidiasis. Control sera were obtained from normal healthy indiv…

Microbiology (medical)CytoplasmAntigens FungalBlotting WesternEnzyme-Linked Immunosorbent AssaySensitivity and SpecificityBlastoconidiumMicrobiologyFungal ProteinsMannansAntigenCell WallCandida albicansmedicineHumansCandida albicansAntibodies FungalMannanMembrane Glycoproteinsbiologymedicine.diagnostic_testCandidiasisGeneral Medicinebiology.organism_classificationmedicine.diseaseCorpus albicansInfectious DiseasesImmunoglobulin GImmunoassaybiology.proteinSystemic candidiasisAntibodyLatex Fixation TestsEuropean Journal of Clinical Microbiology & Infectious Diseases
researchProduct

Tonometers and infectious risk: myth or reality? Efficacy of different disinfection regimens on tonometer tips

2006

Purpose To evaluate the adequacy of common disinfection regimens for disposable tonometer tips and assess if disinfection of reusable prisms or the use of disposable tips is preferable. Methods We used disposable tonometer tips, using the same material and tip diameter of standard Goldmann tonometer prism. Strains of Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus subtilis and Candida albicans were tested according to the European standard guidelines for disinfectants test. Antimicrobial effectiveness of the following disinfection practices has been assessed: dry wipe, Minuten wipes (Alpros), soaking in 3% hydrogen peroxide, 0.5% benzalkonium chloride, and 0.5% Pantasepts for 1, 5, …

Settore MED/07 - Microbiologia E Microbiologia Clinicamedicine.medical_specialtydisinfection regimens on tonometer tips.Bacillaceae InfectionsSettore MED/42 - Igiene Generale E ApplicataCommunicable DiseasesRisk AssessmentTonometry OcularmedicineHumansPseudomonas InfectionsEfficacy of tonometers disinfectionOrganic ChemicalsDisposable EquipmentIntensive care medicineDisinfection methodsSettore MED/30 - Malattie Apparato VisivoOrganic chemicalsbusiness.industryCandidiasisHydrogen PeroxideStaphylococcal InfectionsSurgeryDisinfectionOphthalmologyCommunicable disease transmissionAnti-Infective Agents LocalInfectious riskBenzalkonium CompoundsTonometers and infectious riskBenzalkonium CompoundsbusinessBacillus subtilisDisinfectantsEye
researchProduct

Untargeted Antifungal Treatment in the ICU: Changing Definitions and Labels Do Not Change the Evidence.

2018

N/A

AntifungalAdultmedicine.medical_specialtyAntifungal Agentsmedicine.drug_classbusiness.industry010102 general mathematicsCandidiasisCritical Care and Intensive Care Medicine01 natural sciences03 medical and health sciencesIntensive Care Units0302 clinical medicinemedicineHumans030212 general & internal medicine0101 mathematicsbusinessIntensive care medicineCritical care medicine
researchProduct

Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on …

2017

Abstract Introduction The study objective was to evaluate the efficacy of different dosages of caspofungin in the treatment of invasive candidiasis and aspergillosis, in relation to the probability of pharmacokinetic/pharmacodynamic (PK/PD) target attainment, using modelling and Monte Carlo simulations in critically ill adult patients on continuous haemodiafiltration. Methods Critically ill adult patients on continuous venovenous haemodiafiltration treated with caspofungin were analysed. A population PK model was developed. Four caspofungin dosing regimens were simulated: the licensed regimen, 70 mg/day, 100 mg/day or 200 mg/day. A PK/PD target was defined as the ratio between the area unde…

0301 basic medicineMicrobiology (medical)MaleAntifungal AgentsCandida parapsilosisCritical Illness030106 microbiologyPopulationCandida glabrataHemodiafiltrationMicrobial Sensitivity TestsPharmacologyAspergillosis03 medical and health scienceschemistry.chemical_compoundEchinocandinsLipopeptides0302 clinical medicinePharmacokineticsCaspofunginCandida albicansMedicineHumansPharmacology (medical)Candidiasis Invasive030212 general & internal medicineDosingeducationAgedAged 80 and overInvasive Pulmonary Aspergillosiseducation.field_of_studyMaintenance dosebusiness.industryCandidiasisGeneral MedicineMiddle Agedmedicine.diseaseRegimenInfectious DiseasesAspergilluschemistryPharmacodynamicsFemaleCaspofunginbusinessInternational journal of antimicrobial agents
researchProduct

Candida albicans-epithelial interactions: dissecting the roles of active penetration, induced endocytosis and host factors on the infection process

2012

International audience; Candida albicans frequently causes superficial infections by invading and damaging epithelial cells, but may also cause systemic infections by penetrating through epithelial barriers. C. albicans is a remarkable pathogen because it can invade epithelial cells via two distinct mechanisms: induced endocytosis, analogous to facultative intracellular enteropathogenic bacteria, and active penetration, similar to plant pathogenic fungi. Here we investigated the contributions of the two invasion routes of C. albicans to epithelial invasion. Using selective cellular inhibition approaches and differential fluorescence microscopy, we demonstrate that induced endocytosis contri…

[SDV]Life Sciences [q-bio]lcsh:MedicineYeast and Fungal ModelsPathogenesisCandidiasis OralMolecular Cell BiologyCandida albicanslcsh:ScienceCandida albicansPathogencandida albicans;epithelial interaction;endocytosis;infection0303 health sciencesFungal proteinMultidisciplinaryFungal DiseasesBlood Physiological PhenomenaCadherinsEndocytosisCorpus albicansepithelial interactionCell biologyHost-Pathogen InteractionInfectious Diseases[SDE]Environmental SciencesHost-Pathogen InteractionsMedicineCellular TypesSuperficial MycosesCandidalysinResearch ArticleMycologyBiologyEndocytosisMicrobiologyCell LineMicrobiologyFungal Proteins03 medical and health sciencesModel OrganismsMicroscopy Electron TransmissionCell Adhesion[SDV.BV]Life Sciences [q-bio]/Vegetal BiologyHumansCell adhesionBiology030304 developmental biology030306 microbiologyIntracellular parasitelcsh:RFungiMouth MucosaEpithelial Cellsbiology.organism_classificationinfectionYeastlcsh:Q
researchProduct

The C-terminal antibody binding domain ofCandida albicansmp58 represents a protective epitope during candidiasis

2003

The 58-kDa surface mannoprotein of Candida albicans (mp58) elicits strong antibody responses during infection. Epitope mapping with sera from patients with candidiasis and control individuals indicated the presence of multiple IgG-reactive continuous epitopes on the protein, expanding both the amino- and carboxy-terminal domains and several internal regions. These immunoreactive regions were similar to the ones previously identified using sera from immunized animals. Two of the epitopic regions (including the C-terminal domain) showed increased reactivity with antibodies present in sera from patients with candidiasis as compared to control individuals. Patients who survived the infection di…

medicine.drug_classEnzyme-Linked Immunosorbent AssayMonoclonal antibodyMicrobiologyEpitopeImmunoglobulin GFungal ProteinsEpitopesMiceCandida albicansGeneticsmedicineAnimalsAmino Acid SequenceCandida albicansMolecular BiologyMice Inbred BALB CMembrane GlycoproteinsbiologyCandidiasisAntibodies Monoclonalbiology.organism_classificationDisseminated CandidiasisVirologyCorpus albicansProtein Structure TertiaryEpitope mappingbiology.proteinFemaleAntibodyEpitope MappingFEMS Microbiology Letters
researchProduct

Therapeutic tools for oral candidiasis : current and new antifungal drugs

2019

Background Candidiasis is one of the most common opportunistic oral infections that presents different acute and chronic clinical presentations with diverse diagnostic and therapeutic approaches. The present study carries out a bibliographic review on the therapeutic tools available against oral candidiasis and their usefulness in each clinical situation. Material and Methods Recent studies on treatment of oral candidiasis were retrieved from PubMed and Cochrane Library. Results Nystatin and miconazole are the most commonly used topical antifungal drugs. Both antifungal drugs are very effective but need a long time of use to eradicate the infection. The pharmacological presentations of mico…

AzolesNystatinmedicine.medical_specialtyAntifungal AgentsDatabases FactualMiconazolePyridinesItraconazoleAdministration TopicalAdministration OralReviewAnidulafunginEchinocandins03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCandidiasis OralCaspofunginAmphotericin BNitrilesmedicineHumansDrug InteractionsClotrimazoleFluconazoleGeneral DentistryVoriconazoleOral Medicine and Pathologybusiness.industryClotrimazole030206 dentistryTriazoles:CIENCIAS MÉDICAS [UNESCO]bacterial infections and mycosesDermatologyNystatinOtorhinolaryngologychemistryUNESCO::CIENCIAS MÉDICASAnidulafunginAdministration IntravenousSurgeryCaspofunginMiconazolebusinessFluconazolemedicine.drug
researchProduct

Toll-like receptor 2 is dispensable for acquired host immune resistance to Candida albicans in a murine model of disseminated candidiasis

2004

Previous work by our group showed that Toll-like receptor 2 (TLR2) is essential for activation of innate immunity, playing a major role in the response of macrophages to Candida albicans, triggering cytokine and chemokine expression, and therefore TLR2 -/- mice are more susceptible to systemic primary candidiasis. In this work, we used a murine model of systemic C. albicans infection, in which resistance to reinfection with virulent wild-type cells is induced by prior exposure of mice to a low-virulence agerminative strain of C. albicans (primary sublethal infection), to study the influence of TLR2 gene deletion on (i) the ability to develop an acquired resistance upon vaccination; (ii) the…

Chemokinemedicine.medical_treatmentImmunologyReceptors Cell SurfaceMicrobiologyMicrobiologyInterferon-gammaMiceCandida albicansmedicineAnimalsCandida albicansAntibodies FungalMice KnockoutToll-like receptorMembrane GlycoproteinsInnate immune systembiologyTumor Necrosis Factor-alphaToll-Like ReceptorsCandidiasisbiology.organism_classificationDisseminated CandidiasisInterleukin-12Immunity InnateToll-Like Receptor 2Corpus albicansMice Inbred C57BLTLR2Infectious DiseasesCytokineImmunoglobulin GImmunologybiology.proteinCytokinesMicrobes and Infection
researchProduct

Performance of existing definitions and tests for the diagnosis of invasive fungal diseases other than invasive candidiasis and invasive aspergillosi…

2021

Diagnòstic; Malalties fúngiques invasores; Pneumocystis Diagnóstico; Enfermedades fúngicas invasivas; Pneumocystis Diagnosis; Invasive fungal diseases; Pneumocystis The Fungal Infections Definitions in Intensive Care Unit (ICU) patients (FUNDICU) project aims to provide standard sets of definitions for invasive fungal diseases (IFDs) in critically ill, adult patients, including invasive aspergillosis (IA), invasive candidiasis (IC), Pneumocystis jirovecii pneumonia (PJP), and other non-IA, non-IC IFDs. The first step of the project was the conduction of separated systematic reviews of the characteristics and applicability to critically ill, adult patients outside classical populations at ri…

diagnosis:infecciones bacterianas y micosis::micosis::infecciones fúngicas invasoras [ENFERMEDADES]invasive fungal diseasesPJPPlant ScienceAspergillosis:Bacterial Infections and Mycoses::Mycoses::Invasive Fungal Infections [DISEASES]law.invention0302 clinical medicineIFD; PJP; biomarker; diagnosis; invasive fungal diseases; pneumocystislawDiagnosis:Other subheadings::/diagnosis [Other subheadings]Medicine and Health Sciences030212 general & internal medicinelcsh:QH301-705.50303 health sciences:Natural Science Disciplines::Science::Research::Empirical Research::Qualitative Research [DISCIPLINES AND OCCUPATIONS]EcologyCommunicationPneumocystis jirovecii PneumoniaInvasive candidiasisIntensive care unitInvasive fungal diseasesSystematic reviewbiomarkerIFDMicrobiology (medical)medicine.medical_specialtyEvolutionQualitative evidence:Otros calificadores::/diagnóstico [Otros calificadores]pneumocystisInvestigació qualitativa03 medical and health sciencesBehavior and Systematics:disciplinas de las ciencias naturales::ciencia::investigación::investigación empírica::investigación cualitativa [DISCIPLINAS Y OCUPACIONES]medicineIntensive care medicineEcology Evolution Behavior and SystematicsAdult patients030306 microbiologyCritically illbusiness.industryPneumocystisBiomarker; Diagnosis; IFD; Invasive fungal diseases; PJP; PneumocystisBiomarkermedicine.diseaselnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]lcsh:Biology (General)Micosi - Diagnòsticbusiness
researchProduct